Literature DB >> 2866161

Skin reactivity of unsensitized monkeys upon challenge with staphylococcal enterotoxin B: a new approach for investigating the site of toxin action.

P H Scheuber, J R Golecki, B Kickhöfen, D Scheel, G Beck, D K Hammer.   

Abstract

The correlation between skin tests and emetic responses in unsensitized monkeys was used to elucidate the cellular site of action of staphylococcal enterotoxin B (SEB). Evidence is presented that SEB administered intradermally provoked immediate-type skin reactions associated with mild degranulation of cutaneous mast cells. The cytoplasma showed signs of synthetic and metabolic activity, with formation of vesicles and increased prominence of mitochondria. Carboxymethylation of histidine residues of SEB altered the molecule (cSEB) from more alkaline components to more acidic species with increased microheterogeneity. This modification caused a loss in toxicity and completely abrogated the skin-sensitizing activity without changing the immunological specificity. cSEB, however, could compete with SEB for binding sites on the target cell surface. Previously, compound 48/80-treated skin sites behaved refractively to challenge with SEB, indicating that mediators from cutaneous mast cells are required for SEB-induced skin reactions. Skin reactions as well as emetic responses challenged with SEB were completely inhibited by H2 receptor antagonists and calcium channel blockers but not by H1 antihistamine or competitive antagonists of serotonin. This new approach provides a model for investigating the mechanisms of SEB action.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866161      PMCID: PMC261160          DOI: 10.1128/iai.50.3.869-876.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Two distinct mechanisms for the initiation of mast cell degranulation.

Authors:  D C Morrison; J F Roser; C G Cochrane; P M Henson
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

2.  Human plasma levels of some anti-migraine drugs.

Authors:  J Meier; E Schreier
Journal:  Headache       Date:  1976-07       Impact factor: 5.887

3.  The effects of H1 and H2 receptor antagonism on the response of monkey skin to intradermal histamine, reverse-type anaphylaxis, and passive cutaneous anaphylaxis.

Authors:  B J Hutchcroft; E G Moore; R P Orange
Journal:  J Allergy Clin Immunol       Date:  1979-06       Impact factor: 10.793

4.  Basophil activation by concanavalin A: characteristics of the reaction.

Authors:  P A Siraganian; R P Siraganian
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

5.  A low-viscosity epoxy resin embedding medium for electron microscopy.

Authors:  A R Spurr
Journal:  J Ultrastruct Res       Date:  1969-01

6.  The carboxymethylation of human metmyoglobin.

Authors:  C M Harris
Journal:  J Biol Chem       Date:  1969-04-25       Impact factor: 5.157

7.  Hypersensitivtiy responses in monkeys. VI. P-K, histamine, 48-80 responses after challenges with heterologous antigen or the other agents.

Authors:  S M Feinberg; A R Reinberg; F Lee
Journal:  Clin Allergy       Date:  1973-12

8.  Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes.

Authors:  M P Langford; G J Stanton; H M Johnson
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

9.  Mechanisms of oral staphylococcal enterotoxin B-induced emesis in the monkey (38553).

Authors:  M R Elwell; C T Liu; R O Spertzel; W R Beisel
Journal:  Proc Soc Exp Biol Med       Date:  1975-02

10.  The effect of locally injected vasoactive amines on the elicitation of delayed-type hypersensitivity.

Authors:  A Schwartz; P W Askenase; R K Gershon
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

View more
  19 in total

Review 1.  T lymphocyte-stimulating microbial toxins as "superantigens".

Authors:  B Fleischer
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

2.  Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres.

Authors:  J Tseng; J L Komisar; R N Trout; R E Hunt; J Y Chen; A J Johnson; L Pitt; D L Ruble
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

3.  Protection against the staphylococcal enterotoxin-induced intestinal disorder in the monkey by anti-idiotypic antibodies.

Authors:  B Reck; P H Scheuber; W Londong; B Sailer-Kramer; K Bartsch; D K Hammer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

4.  Anti-idiotypic antibodies that inhibit immediate-type skin reactions in unsensitized monkeys on challenge with staphylococcal enterotoxin.

Authors:  U Bamberger; P H Scheuber; B Sailer-Kramer; K Bartsch; A Hartmann; G Beck; D K Hammer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

Review 5.  Contemporary issues: diseases with a food vector.

Authors:  D L Archer; F E Young
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

6.  Cytokine secretion induced by superantigens in peripheral blood mononuclear cells, lamina propria lymphocytes, and intraepithelial lymphocytes.

Authors:  K Sperber; L Silverstein; C Brusco; C Yoon; G E Mullin; L Mayer
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

Review 7.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

8.  Biological activities of staphylococcal enterotoxin type A mutants with N-terminal substitutions.

Authors:  T O Harris; M J Betley
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

9.  Biochemical and mutational analysis of the histidine residues of staphylococcal enterotoxin A.

Authors:  M Hoffman; M Tremaine; J Mansfield; M Betley
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins.

Authors:  T O Harris; D Grossman; J W Kappler; P Marrack; R R Rich; M J Betley
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.